During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...

The Cardiovascular Prevention CME Program aligns with the First Pillar of the Malaysian Health White Paper, which is aimed a ...

SARS-CoV-2 disrupts cholesterol metabolism by using its ORF3a protein to sequester cholesterol in lysosomes, reducing BMP ...

A little more than a month after AstraZeneca jumped into the fray with the purchase of a rival heart drug candidate, Eli ...

"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...

Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patients ...

Obesity is a risk factor for many serious medical diseases such as hypertension, dyslipidemia, Type 2 diabetes and coronary artery disease. It’s also a risk factor for many psychological ills such as ...

There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.

The above health publication claims that a research involving 8,000 adults, revealed that eating late at night was linked to ...